Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regression of Fatty Heart by Valsartan
NCT00745953Phase 4Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Aug 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in myocardial steatosis, metabolic syndrome, sponsored by UT Southwestern Medical Center. Planned start Aug 2007; status: withdrawn.
02
Drugs
valsartan
03
Conditions
myocardial steatosismetabolic syndrome
Beyond the preview
Go deeper on NCT00745953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00745953.